Jordan Silberman, MD, PhD
Senior Director, Health Economics and Outcomes Research (HEOR), Cardiometabolic Health
San Francisco Bay Area · 1 connectionNot on Unlinked · Imported profile. Is this you? Claim it
Is this about you? Request removal
About
Resume/CV: tinyurl.com/JSilberman Jordan Silberman, MD, PhD, is a Senior Director of Health Economics and Outcomes Research (HEOR) at Eli Lilly and previously was a Director of Clinical Analytics and Research at Elevance Health. At Eli Lilly, Jordan leads clinical studies of tirzepatide, with a focus on regulatory-grade real-world evidence (RWE) in cardiometabolic health. In his prior role at Elevance Health, Jordan led development of a novel evidence assessment framework for digital health technologies (tinyurl.com/edefined), spearheaded a partnership with the Digital Medicine Society, and led Elevance's Digital Health Evidence Committee (DHEC). In addition, he led scientific and statistical strategy for the Asthma Digital Study (tinyurl.com/asdigstudy), a randomized clinical trial. A behavioral scientist and experienced data analyst, Jordan has 15+ years of experience in digital health technology. He earned an MD (honors in research), a PhD in behavioral science, and a certificate in statistics from the University of Rochester, as well as a master’s degree in behavioral science from the University of Pennsylvania.
Experience
Jan 2026 to Apr 2026
Jan 2020 to Jan 2026
Education
Doctor of Medicine (MD), Medicine
2007 to 2015
PhD, Psychology
2009 to 2013
Certificate in Quantitative Methods (statistics)
2009 to 2013